查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454110

肝病診斷市場，按技術、最終用途、國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Liver Disease Diagnostics Market, By Technique, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 292 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年肝病診斷市場規模為376.69億美元，2024年至2032年複合CAGR為6.5%。

肝病診斷市場-市場動態

慢性肝病盛行率上升推動市場成長

預計推動肝病診斷市場的主要原因之一是急性和慢性肝病的發生率不斷增加。例如，世界衛生組織估計，2020 年全球有 83 萬人死於肝癌。此外，根據 2021 年 6 月發表的題為「慢性肝病的全球流行病學」的研究論文，慢性肝病 (CLD) 是導致死亡和發病的主要原因之一，該疾病影響著全球約 15 億人。上述統計數據推動了市場成長。

肝病診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.5% 左右的CAGR成長

基於技術細分，成像領域預計將在預測期內佔據顯著的市場佔有率

根據最終用途細分，預計醫院細分市場將在預測期內佔據最大的市場佔有率

按地區分類，2023 年北美市佔率最大

肝病診斷市場-細分分析：

全球肝病診斷市場根據技術、最終用途和地區進行細分。

根據該技術，肝病診斷市場分為切片、實驗室檢查、內視鏡檢查、影像等。預計成像領域將在預測期內佔據顯著的市場佔有率。這是因為肝病診斷市場的主要公司擴大致力於創造尖端成像技術。肝功能是在實驗室環境中利用尿液、血液和其他液體樣本進行診斷的。然而，影像包括多種測試，例如 CT、MRI、X 光、超音波和磁振造影 (MRI)。

根據最終用途，全球肝病診斷市場分為實驗室、醫院和其他。預計醫院部門在預測期內將佔據最大的市場佔有率，因為大多數患者依賴診斷測試設備儲備充足的醫院。肝病診斷市場正在擴大，因為醫院為患者提供盡可能最好的治療並促進早期識別和診斷。預計醫療保健基礎設施的持續發展將改善現有的醫院設施。

肝病診斷市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美在預測期內將佔據最大的市場佔有率。主要參與者的存在和大量的研發支出是預計推動該地區肝病診斷市場成長的兩個因素。此外，向個人提供醫療診斷資訊的機構的存在預計將刺激肝病診斷市場的擴大。 GetPalliativeCare.org 就是此類網站之一，該網站提供有關診斷程序（包括 CT 掃描、內視鏡檢查和活組織檢查）的姑息治療資訊。例如，2020 年最常見的肝臟疾病是非酒精性脂肪肝，影響超過 700 萬人。根據加拿大肝臟基金會的 2021 年報告，肝癌是加拿大最致命且成長最快的癌症。

肝病診斷市場-競爭格局：

該市場的主要參與者包括波士頓科學公司、美國實驗室控股公司、賽默飛世爾科技公司、朗道克斯實驗室有限公司、雅培、羅氏有限公司、富士膠片公司、堀場醫療、西門子醫療有限公司和珀金埃爾默。

最近的發展：

2023 年10 月，頂級提供者PathAI Diagnostics 推出了人工智慧輔助實驗室設計測試(LDT)，用於對代謝功能障礙相關的脂肪肝病(MASLD) 和代謝功能障礙相關的脂肪性肝炎(MASH) 進行組織學評分和分期的實驗室服務。

目錄

第1章：肝病診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 肝病診斷市場片段（按技術）
    • 按最終用途分類的肝病診斷市場片段
    • 按國家/地區分類的肝病診斷市場片段
    • 按地區分類的肝病診斷市場片段
  • 競爭洞察

第 3 章：肝病診斷主要市場趨勢

  • 肝病診斷市場促進因素
    • 市場促進因素的影響分析
  • 肝病診斷市場限制
    • 市場限制影響分析
  • 肝病診斷市場機會
  • 肝病診斷市場未來趨勢

第 4 章：肝病診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：肝病診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：肝病診斷市場格局

  • 2023 年肝病診斷市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：肝病診斷市場 - 按技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 活體組織切片
    • 實驗室測試
    • 內視鏡檢查
    • 影像學
    • 其他

第 8 章：肝病診斷市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 實驗室
    • 醫院
    • 其他

第 9 章：肝病診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美肝病診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲肝病診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區肝病診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲肝病診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲肝病診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析-肝病診斷產業

  • 競爭儀表板
  • 公司簡介
    • Boston Scientific Corporation
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Fujifilm Corporation
    • Horiba Medical
    • Siemens Healthcare GmbH
    • PerkinElmer

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2291

REPORT HIGHLIGHT

Liver Disease Diagnostics Market size was valued at USD 37,669 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Any ailment that affects the liver is referred to as "liver disease" in general. Although the causes of these disorders vary, they can all harm the liver and impair its ability to operate. Liver disorders include hepatitis, alcoholic fatty liver disease, primary biliary cirrhosis (PBC), primary sclerosing cholangitis, Wilson's disease, liver cirrhosis, and jaundice can all be diagnosed with the use of liver disease tests. Different procedures, including imaging, laboratory testing, endoscopy, and biopsy, can be used to identify liver disorders.

Liver Disease Diagnostics Market- Market Dynamics

Rising prevalence of chronic liver disease drive market growth

One of the main reasons anticipated to propel the liver disease diagnostics market is the increasing frequency of both acute and chronic liver illnesses. For instance, the WHO estimates that 830,000 deaths worldwide in 2020 were attributable to liver cancer. Furthermore, one of the main causes of death and morbidity is chronic liver disease (CLD), which affects approximately 1.5 billion people globally, according to a study paper titled "Global Epidemiology of Chronic Liver Disease" that was published in June 2021. Thus, the aforementioned stats drive the market growth.

Liver Disease Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on technique segmentation, the imaging segment is expected to hold a prominent market share over the forecast period

Based on end-use segmentation, the Hospitals segment is expected to hold the largest market share during the forecast period

Based on region, North America held the largest market share in 2023

Liver Disease Diagnostics Market- Segmentation Analysis:

The Global Liver Disease Diagnostics Market is segmented based on Technique, End-use and Region.

Based on the technique, the Liver Disease Diagnostics market is bifurcated into Biopsy, Laboratory tests, Endoscopy, Imaging and Others. The Imaging segment is expected to hold a prominent market share over the forecast period. This is explained by the increasing number of efforts made to create cutting-edge imaging techniques by major companies in the liver disease diagnostics market. Liver function is diagnosed in lab settings utilizing urine, blood, and other fluid samples. However, imaging comprises several tests such as CT, MRI, X-ray, ultrasound, and magnetic resonance imaging (MRI).

Based on the end-use, the global Liver Disease Diagnostics market is segmented into Laboratories, Hospitals and Others. The Hospitals segment is expected to hold the largest market share during the forecast period because most patients depend on hospitals that are well-stocked with diagnostic testing equipment. The market for liver disease diagnostics is expanding because hospitals give patients the best treatment possible and facilitate early identification and diagnosis. It is also expected that the continuous infrastructure development in healthcare would improve the current hospital facilities.

Liver Disease Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold the largest market share during the forecast period. The presence of major players and significant R&D expenditures are two factors that are anticipated to fuel the growth of the liver disease diagnostics market in the area. Moreover, the existence of institutions that furnish individuals with information concerning medical diagnosis is anticipated to stimulate the expansion of the liver disease diagnostics market. One such website is GetPalliativeCare.org, which offers information on palliative care about diagnostic procedures including CT scans, endoscopies, and biopsies. For instance, the most common liver condition in 2020 was non-alcoholic fatty liver disease, affecting over 7 million individuals. According to the Canadian Liver Foundation's 2021 report, liver cancer is the most deadly and rapidly growing kind of cancer in Canada.

Liver Disease Diagnostics Market- Competitive Landscape:

The key players operating in the market are Boston Scientific Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Abbott, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH and PerkinElmer.

Recent Developments:

In October 2023, an AI-assisted laboratory-designed test (LDT) for the histologic scoring and staging of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) was introduced by PathAI Diagnostics, a top provider of laboratory services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Boston Scientific Corporation

Laboratory Corporation of America Holdings

Thermo Fisher Scientific Inc.

Randox Laboratories Ltd.

Abbott

F. Hoffmann-La Roche Ltd.

Fujifilm Corporation

Horiba Medical

Siemens Healthcare GmbH

PerkinElmer

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Biopsy
  • Laboratory tests
  • Endoscopy
  • Imaging
  • Others

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Hospitals
  • Others

GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Liver Disease Diagnostics Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Liver Disease Diagnostics Market Snippet by Technique
    • 2.1.2.Liver Disease Diagnostics Market Snippet by End-use
    • 2.1.3.Liver Disease Diagnostics Market Snippet by Country
    • 2.1.4.Liver Disease Diagnostics Market Snippet by Region
  • 2.2.Competitive Insights

3.Liver Disease Diagnostics Key Market Trends

  • 3.1.Liver Disease Diagnostics Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Liver Disease Diagnostics Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Liver Disease Diagnostics Market Opportunities
  • 3.4.Liver Disease Diagnostics Market Future Trends

4.Liver Disease Diagnostics Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Liver Disease Diagnostics Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Liver Disease Diagnostics Market Landscape

  • 6.1.Liver Disease Diagnostics Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Liver Disease Diagnostics Market - By Technique

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Technique, 2023 & 2032 (%)
    • 7.1.2.Biopsy
    • 7.1.3.Laboratory tests
    • 7.1.4.Endoscopy
    • 7.1.5.Imaging
    • 7.1.6.Others

8.Liver Disease Diagnostics Market - By End-use

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By End-use, 2023 & 2032 (%)
    • 8.1.2.Laboratories
    • 8.1.3.Hospitals
    • 8.1.4.Others

9.Liver Disease Diagnostics Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Liver Disease Diagnostics Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Liver Disease Diagnostics Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Liver Disease Diagnostics Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Liver Disease Diagnostics Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Liver Disease Diagnostics Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Liver Disease Diagnostics Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Boston Scientific Corporation
    • 10.2.2.Laboratory Corporation of America Holdings
    • 10.2.3.Thermo Fisher Scientific Inc.
    • 10.2.4.Randox Laboratories Ltd.
    • 10.2.5.Abbott
    • 10.2.6.F. Hoffmann-La Roche Ltd.
    • 10.2.7.Fujifilm Corporation
    • 10.2.8.Horiba Medical
    • 10.2.9.Siemens Healthcare GmbH
    • 10.2.10.PerkinElmer

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Disease Diagnostics Market: Technique Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technique
  • TABLE Global Liver Disease Diagnostics Market, by Technique 2019-2032 (USD Million)
  • TABLE Liver Disease Diagnostics Market: End-use Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Liver Disease Diagnostics Market, by End-use 2019-2032 (USD Million)
  • TABLE Liver Disease Diagnostics Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Disease Diagnostics Market, by Region 2019-2032 (USD Million)
  • TABLE North America Liver Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Liver Disease Diagnostics Market, by Technique, 2019-2032 (USD Million)
  • TABLE North America Liver Disease Diagnostics Market, by End-use, 2019-2032 (USD Million)
  • TABLE Europe Liver Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Liver Disease Diagnostics Market, by Technique, 2019-2032 (USD Million)
  • TABLE Europe Liver Disease Diagnostics Market, by End-use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liver Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liver Disease Diagnostics Market, by Technique, 2019-2032 (USD Million)
  • TABLE Asia Pacific Liver Disease Diagnostics Market, by End-use, 2019-2032 (USD Million)
  • TABLE Latin America Liver Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Liver Disease Diagnostics Market, by Technique, 2019-2032 (USD Million)
  • TABLE Latin America Liver Disease Diagnostics Market, by End-use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liver Disease Diagnostics Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liver Disease Diagnostics Market, by Technique, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Liver Disease Diagnostics Market, by End-use, 2019-2032 (USD Million)